People Staff

Guillem Pascual Pastó

Investigador

Research group

Pascual-Pastó G, McIntyre B, Giudice AM, Alikarami F, Morrissey A, Matlaga S, Hofmann TJ, Burgeño-Sandoval V, Harvey K, Martinez D, Shah AC, Foster JB, Pogoriler J, Eagle RC, Carcaboso AM, Shields CL, Leahey AM and Bosse KR Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T Cells CLINICAL CANCER RESEARCH 2024. 30(16): 3578-3591.
Aschero MR, Ganiewich D, Lamas G, Restrepo-Perdomo CA, Ottaviani D, Zugbi S, Camarero S, Néspoli E, Cuadrado-Vilanova M, Pérez-Jaume S, Pascual-Pastó G, Sampor C, Grigorovski N, Salas B, Suñol M, Carcaboso AM, Mora J, de Dávila MTG, Doz F, Radvanyi F, Abramson DH, Llera AS, Schaiquevich PS, Lubieniecki F and Chantada G Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma PEDIATRIC BLOOD & CANCER 2024. 71(1): .
Pascual-Pastó G, Resa-Parés C, Castillo H, Aschero MR, Baulenas-Farrés M, Vilà-Ubach M, Burgeño-Sandoval V, Balaguer-Lluna L, Cuadrado-Vilanova M, Gene-Olaciregui N, Martinez N, Pérez-Jaume S, de Alava, E, Tirado, OM, Lavarino C, Mora J and Carcaboso AM Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma BIOCHEMICAL PHARMACOLOGY 2023. 208: 115408-115408.

More Publications

Project name:: Next-generation immunotherapies for pediatric solid tumors
Leader: Guillem Pascual Pastó
Funding entities:: Ministerio De Ciencia E Innovacion
Code: RYC2024-048764-I
Starting - finishing date:: 2026 - 2030

Project name:: SGR 2017_Grup de Recerca en tumors del desenvolupament
Leader: Jaume Mora Graupera
Funding entities:: Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
Code: 2017 SGR 01672
Starting - finishing date:: 2017 - 2021

Project name:: Caracterización y relevancia del entorno epigenético en el desarrollo del sarcoma de Ewing
Leader: Jaume Mora Graupera
Funding entities:: Instituto de Salud Carlos III (ISCIII)
Code: PI16/00245
Starting - finishing date:: 2017 - 2020

More projects